The origin of cancer directly from the normal stem cell was mainly supported by reports that identified the CD34+/CD38- tumor subpopulation as the fraction that can initiate leukemia upon transfer to nonobese diabetic-severe combined immunodeficiency (NOD/SCID) recipient mice. The gene discussed is CD38; the disease is leukemia.